Cited by 119Cancer Cells and MetastasisTGF-β signaling in diseasesCellular Mechanics and Interactions

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling

Open access
Barker, Holly E., Bird, Demelza, Lang, Georgina, Erler, Janine T.·2013·Molecular Cancer Research

Published version of a preprint

Abstract

Cancer-associated fibroblasts enhance cancer progression when activated by tumor cells through mechanisms not yet fully understood. Blocking mammary tumor cell–derived lysyl oxidase-like 2 (LOXL2) significantly inhibited mammary tumor cell invasion and metastasis in transgenic and orthotopic mouse models. Here, we discovered that tumor-derived LOXL2 directly activated stromal fibroblasts in the tumor microenvironment. Genetic manipulation or antibody inhibition of LOXL2 in orthotopically grown mammary tumors reduced the expression of α-smooth muscle actin (α-SMA). Using a marker for reticular fibroblasts, it was determined that expression of α-SMA was localized to fibroblasts recruited from the host tissue. This marker also revealed that the matrix present in tumors with reduced levels of LOXL2 was more scattered compared with control tumors which exhibited matrices with dense, parallel alignments. Importantly, in vitro assays revealed that tumor-derived LOXL2 and a recombinant LOXL2 protein induced fibroblast branching on collagen matrices, as well as increased fibroblast-mediated collagen contraction and invasion of fibroblasts through extracellular matrix. Moreover, LOXL2 induced the expression of α-SMA in fibroblasts grown on collagen matrices. Mechanistically, it was determined that LOXL2 activated fibroblasts through integrin-mediated focal adhesion kinase activation. These results indicate that inhibition of LOXL2 in tumors not only reduces tumor cell invasion but also attenuates the activation of host cells in the tumor microenvironment. Implications: These findings reveal new insight into the mechanisms of fibroblast activation, a novel function of LOXL2, and further highlight the importance of generating LOXL2-targeted therapies for the prevention of tumor progression and metastasis. Mol Cancer Res; 11(11); 1425–36. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-13-0033-t

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Tarin, 1969, Ultrastructural features of wound healing in mouse skin, J Anat, 105, 189

Cited by

Sorted by citations

See all 119

Metadata

Authors
Barker, H. E., Bird, D., Lang, G., & Erler, J. T.
Affiliations
University of Copenhagen (DK)
Corresponding author
Erler, Janine T.
Venue
Molecular Cancer Research
Published
2013-11-01
Volume
11
Issue
11
Pages
1425-1436
ISSN
  • 1541-7786 (ISSN-L)
  • 1557-3125
OpenAlex
W2105524728
Cited by
119
References
52
Citations by year
2026: 4 · 2025: 7 · 2024: 15 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 10 · 2019: 13 · 2018: 9 · 2017: 10 · 2016: 11 · 2015: 8 · 2014: 8
FWCI
4.82
Type
journal article
Language
en
Open access
Locations
  • Molecular Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
Cancer Research UK (A11355, A10433)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords
LOXL2, cancer-associated fibroblasts, fibroblast activation, focal adhesion kinase, integrin signaling, tumor microenvironment, mammary tumors, tumor invasion, metastasis, alpha-smooth muscle actin, collagen matrix, extracellular matrix remodeling
MeSH terms
Actins, Amino Acid Oxidoreductases, Animals, Cell Adhesion, Collagen, Extracellular Matrix, Female, Fibroblasts, Mammary Neoplasms, Experimental, Mice, Inbred C57BL, Neoplasm Invasiveness, Signal Transduction, Gene Expression Regulation, Neoplastic, 3T3 Cells, Cell Line, Tumor, Cell Proliferation, Mice, Focal Adhesion Kinase 1, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review